biotech · Atopic Dermatitis · Asthma · APGE
Apogee Therapeutics
Apogee Therapeutics is a biotech organization headquartered in WALTHAM, MA, USA. It trades on NYSE under ticker APGE. Primary therapeutic focus areas include Atopic Dermatitis, Asthma, Carcinoma, Hepatocellular, Diffuse
WALTHAM, MA, USA HQ
2022 Founded
293 Employees
Public company Type
APGE · NYSE Ticker
Company details
- Status
- Public
- HQ
- WALTHAM, MA, USA
- Founded
- 2022
- Employees
- 293
- Programs
- 8
- Drugs
- 2
- Patents
- 7
Opaganib
Phase 2 · small molecule · Multiple Myeloma
Opaganib for Multiple Myeloma is a Phase 2 program (small_molecule) at Apogee Therapeutics with 1 ClinicalTrials.gov record(s).
Internal code Pro00062304
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Apogee Therapeutics
- Phase
- Phase 2
- Modality
- small_molecule
- Indication
- Multiple Myeloma
- Status
- terminated
- Trials
- 1